UNSPSC 51451602: Ciclobendazole or cyclobendazole

This classification denotes an antihelminthic agent with the molecular formula C13H13N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JF3KQ40J31, chemically known as 2-benzimidazolecarbamic acid, 5-(cyclopropylcarbonyl)-, methyl ester but generally known as ciclobendazole, which bears US NIH Compound Identifier 35803. European Medicines Agency schedules Ciclobendazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06240MIG.

UNSPSC 51451602 Ciclobendazole or cyclobendazole, a Commodity code, shows minimal relevant recent activity in state and local procurement. The two opportunities tagged under this code do not involve ciclobendazole or cyclobendazole at all — the Illinois Department of Public Health awarded a pharmaceutical warehouse contract for Doxycycline Hyclate and Ciprofloxacin Hydrochloride, and Seminole County, Florida solicited Naloxone and Safe Drug Deactivation Systems. These mismatches suggest the code is either rarely used in state and local procurement or has been incorrectly applied to unrelated pharmaceutical purchases in the available records.

No active solicitations for ciclobendazole or cyclobendazole appear in the recent opportunities block. The tagged Illinois award, valued at $2,999,999.11 over three years through the MMCAP Infuse consortium to Chartwell Rx LLC, was completed in August 2026 and is not an open opportunity. Business development activity under this code should focus on understanding whether ciclobendazole demand exists within state health departments, animal health programs, or veterinary supply chains, as the public procurement record currently provides no guidance on actual buying patterns or issuing bodies for this specific pharmaceutical.